Loading...
Loading...
Clinical decision support tool. Does not replace professional veterinary judgment. Always verify recommendations with current references.
Thinking about this breed for your home? Read the owner suitability guide
| Condition | Prevalence | Onset | Severity | Screening |
|---|---|---|---|---|
| Complement 3 (C3) Deficiency | Breed-specific — Brittanys are the only dog breed described | Congenital — recurrent infection from puppyhood | SEVERE | Serum C3 assay in any Brittany pup with recurrent pyoderma, pneumonia or sepsis that clears on antibiotics and returns. Homozygotes are also predisposed to membranoproliferative glomerulonephritis. |
| Spinal Muscular Atrophy | Breed-specific hereditary motor neuron disease | 6 weeks-1 year depending on form | SEVERE | Progressive symmetric weakness and muscle atrophy without pain in a young Brittany — EMG and referral rather than an orthopedic work-up. |
| Idiopathic Epilepsy | Elevated | 1-5 years | SEVERE | Minimum database plus bile acids to exclude metabolic causes before labelling idiopathic. Owner seizure diary with video guides therapy more than any single test. |
| Progressive Retinal Atrophy | Elevated | 3-7 years | SEVERE | Annual CAER exam; breed-appropriate genetic test where one is offered. Night blindness is the first owner-visible sign. |
| Hip Dysplasia | Elevated for a mid-sized sporting breed | 1-2 years | MODERATE RISK | OFA or PennHIP evaluation by age 2. |
| Hypothyroidism | Elevated | 4-8 years | MILD | Total T4 with TSH annually after age 4. |